Fed. Circ. Affirms Ruling Axing 4 Purdue OxyContin Patents
The Federal Circuit on Monday affirmed a lower court's decision that four patents on Purdue Pharma LP's painkiller OxyContin are invalid as anticipated or obvious in a win for four generics...To view the full article, register now.
Already a subscriber? Click here to view full article